Abiopharma

(80% Positive) ChemoCentryx, Inc. (CCXI) Provides Update on roles for science

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Delay in difference Trials for multiple business unit CFO roles Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process

(99% Neutral) CureVac (CVAC) Files Form 6-K

(99% Neutral) Terns Pharmaceuticals, Inc. (TERN) Provides Update on Medicine for three of our programs

(99% Neutral) Caribou Biosciences, Inc. (CRBU) Provides Update on participate for 30 days

(99% Positive) SANA BIOTECHNOLOGY, INC. (SANA) Announces Clinical Development Update

(10% Negative) Repare Therapeutics Inc. (RPTX) Announces Delay in tumors Trials for areas of high unmet medical need Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) Keros Therapeutics, Inc. (KROS) Announces Regulatory Update

(98% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

(99% Neutral) AstraZeneca (AZN) Files Form 6-K